1. Home
  2. RTC vs LCTX Comparison

RTC vs LCTX Comparison

Compare RTC & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTC
  • LCTX
  • Stock Information
  • Founded
  • RTC 2003
  • LCTX 1990
  • Country
  • RTC China
  • LCTX United States
  • Employees
  • RTC N/A
  • LCTX N/A
  • Industry
  • RTC Specialty Chemicals
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RTC Industrials
  • LCTX Health Care
  • Exchange
  • RTC Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • RTC 171.1M
  • LCTX 165.6M
  • IPO Year
  • RTC N/A
  • LCTX N/A
  • Fundamental
  • Price
  • RTC $7.29
  • LCTX $0.89
  • Analyst Decision
  • RTC
  • LCTX Strong Buy
  • Analyst Count
  • RTC 0
  • LCTX 3
  • Target Price
  • RTC N/A
  • LCTX $5.67
  • AVG Volume (30 Days)
  • RTC 15.5K
  • LCTX 432.3K
  • Earning Date
  • RTC 03-14-2024
  • LCTX 08-08-2024
  • Dividend Yield
  • RTC N/A
  • LCTX N/A
  • EPS Growth
  • RTC N/A
  • LCTX N/A
  • EPS
  • RTC N/A
  • LCTX N/A
  • Revenue
  • RTC $71,896,698.00
  • LCTX $6,186,000.00
  • Revenue This Year
  • RTC N/A
  • LCTX N/A
  • Revenue Next Year
  • RTC N/A
  • LCTX $119.00
  • P/E Ratio
  • RTC N/A
  • LCTX N/A
  • Revenue Growth
  • RTC N/A
  • LCTX N/A
  • 52 Week Low
  • RTC $2.48
  • LCTX $0.77
  • 52 Week High
  • RTC $40.00
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • RTC 50.17
  • LCTX 48.84
  • Support Level
  • RTC $7.02
  • LCTX $0.83
  • Resistance Level
  • RTC $7.59
  • LCTX $0.94
  • Average True Range (ATR)
  • RTC 0.64
  • LCTX 0.06
  • MACD
  • RTC -0.06
  • LCTX 0.00
  • Stochastic Oscillator
  • RTC 56.28
  • LCTX 46.23

About RTC Baijiayun Group Ltd.

Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: